Grant / AwardRoutine 10/100
filed 2026-10-02ACBoard
Anderson Kenneth Carl - Director - $11.5K
This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy.
View source filingC
SEC EDGAR - Form 4 insider activity
C4 Therapeutics, Inc. $CCCC
Tracked equity - 2 filings indexed by Nortis
Nortis signal thesis
Recent activity is mostly routine or balanced.
0
OM buys - 90d
0
OM sells - 90d
2
Routine filings
0
Cluster filings
$14.5K
Largest trade
10/100
Avg signal score
Filing tape
Recent filings
Grant / AwardRoutine 10/100
filed 2026-10-02GRBoard
GROGAN DONNA ROY - Director - $14.5K
This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy.
View source filing